How exercise boosts longevity, prolongs the health span

Translate to Spanish or other 102 languages!

It may be common knowledge that maintaining a regular exercise routine is important to every aspect of human health. Image for illustration purposes
It may be common knowledge that maintaining a regular exercise routine is important to every aspect of human health. Image for illustration purposes
- Advertisement -

Medical News Today

It may be common knowledge that maintaining a regular exercise routine is important to every aspect of human health.

In addition to this, an increasing amount of recent evidence shows just how important it is to keep up that exercise routine as we age to boost longevity and increase our health span — or the number of healthy years that a person lives.

- Advertisement -

Follow the link below to medical News today to read the full story:

https://www.medicalnewstoday.com/articles/exercise-healthy-aging-latest-evidence-study-roundup

Information source: https://www.medicalnewstoday.com

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

Study: Weight Loss Drugs Cut Risk of Four Cancers by Half or More

Medical News Today The use of glucagon-like peptide-1 (GLP-1) receptor agonistTrusted Source medications continues...

Summer Readiness: Keep Your Family Safe with These Heat Tips

The National Weather Service has several tips and warnings with summer temperatures hitting well over the 100-degree mark.

DHR Health To Host 20th Annual “Fishing for Hope” Tournament, August 22nd

DHR Health invites the community to cast a line for a cause at its 20th Annual Fishing for Hope Tournament. The event is set for August 22, 2026, at Jim’s Pier on South Padre Island.

FDA Approves Expanded Use of Kidney Cancer Treatment Rooted in UTSW Discovery

Belzutifan, a first-in-class drug that arose from scientific discoveries at UT Southwestern Medical Center, has been approved by the Food and Drug Administration to treat some patients with earlier stage kidney cancers in combination with an immunotherapy drug. This move marks the latest expansion of belzutifan’s indications after it was originally approved in 2021.
- Advertisement -